Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures. - Wikidata - wikimedia - TriplyDB

Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures.

Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures.

http://www.wikidata.org/entity/Q42917130

about

Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential Potential Role of MicroRNA-210 as Biomarker in Human Cancers Detection: A Meta-Analysis Deregulation of MicroRNAs in Gastric Lymphomagenesis Induced in the d3Tx Mouse Model of Helicobacter pylori Infection Identification of microRNAs as potential biomarker for gastric cancer by system biological analysis.Abundant circulating microRNAs in breast cancer patients fluctuate considerably during neoadjuvant chemotherapy.MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.Viral miRNAs in plasma and urine divulge JC polyomavirus infection.Regulation of cancer metastasis by microRNAs.Machine learning applications in cancer prognosis and prediction Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker Integrating omics technologies to study pulmonary physiology and pathology at the systems level.miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy.Analysis of Serum microRNA Expression Profiles and Comparison with Small Intestinal microRNA Expression Profiles in Weaned Piglets Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.MicroRNAs as biomarkers in leukemia.RNA viruses and microRNAs: challenging discoveries for the 21st century.Usefulness of traditional serum biomarkers for management of breast cancer patients.Circulating human microRNAs are not linked to JC polyomavirus serology or urinary viral load in healthy subjects.miRNAs as non-invasive biomarkers for lung cancer diagnosis.Toward biosensors for the detection of circulating microRNA as a cancer biomarker: an overview of the challenges and successes.Insights into the potential use of microRNAs as a novel class of biomarkers in esophageal cancer.Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival.Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrence.Preliminary evaluation of circulating microRNAs as potential biomarkers in paracoccidioidomycosis.Prognostic value of circulating microRNA-21 in digestive system cancers: a meta-analysis.Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis.Effect of SMYD3 on the microRNA expression profile of MCF-7 breast cancer cells.Molecular profile of liquid biopsies: next generation biomarkers to improve lung cancer treatment.Lab-on-a-Chip Platforms for Detection of Cardiovascular Disease and Cancer Biomarkers.Independent and combined effects of environmental factors and miR-126, miR-143, and miR-145 on the risk of coronary heart disease.miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.Diagnostic value of circulating microRNAs as biomarkers for breast cancer: a meta-analysis study.Biobanks and scientists: supply and demand.MicroRNAs in regulation of triple-negative breast cancer progression MicroRNA-195 as a diagnostic biomarker in human cancer detection: A meta-analysis

P2860

Q26782613-6803B8BE-08C3-454B-A237-46E5454411C5 Q26786404-78DE3833-D6AB-4D63-92D4-00F3B70443A0 Q33689752-03D7D5A2-6961-40C8-A34F-BB4446D658B8 Q33758852-ACEC1031-CD49-4140-BBC8-B87A6AD1221D Q33844289-75EA5351-232E-46BA-9C2A-BB2976688510 Q33962495-A07F74BA-55FB-4398-82BF-0FD1425689E7 Q34208184-93C757E4-29F5-4098-8535-21C210CF7A18 Q35052860-98AAC379-34BE-489E-8932-038D6459FDAC Q35143671-7918B7A1-C669-4E89-8ACD-9D26531E660B Q35247522-A684C0A7-1B1C-4524-ADDE-971CBDA5804B Q35413415-4498BCC7-7675-4F26-93CE-BC501826BE0F Q35681504-3BF223F4-F000-4B17-834A-202041899016 Q36134672-D36CCF39-50B9-4591-AFE5-5EC213F1EC9A Q36214432-A73C402B-6345-423B-840A-48B80A9FC349 Q37043773-1BFC8359-63F0-4D76-A66B-FBA1DEBC3FDE Q37346014-E8C2FF5A-167F-4D67-9936-CD141A955B67 Q37375636-397ABEAA-F583-4005-8BBB-0F1F0CA02839 Q37621983-3F996F50-DBAC-49C8-BD31-6E08F47D2C32 Q38221221-84781DFF-DE9C-45C1-9ACB-B42847EE77DE Q38296132-1849B931-7D41-4B93-90E5-45650B03E5E6 Q38383917-44DAE681-ACED-4045-A01F-7A06E0617167 Q39069297-CFBB318F-332F-408B-B3A5-34F8E7D5B90F Q40043175-CB8FE5C2-07C7-4D1E-B659-2B2106DD49E8 Q40234466-B67AFC65-35E9-4BDC-A977-3701A93E130E Q40714344-F46213CC-0DC9-4237-97C3-9A4FB4DDE548 Q40965602-70630561-83EB-419C-87BE-B74F84235865 Q41143586-A8051040-BD24-45FD-BC72-CB34C10F17E0 Q42129522-5CA1E744-488B-42C4-991D-57481F2CCDDB Q47274844-CBF2BF9E-D3B6-408A-A923-1DE6343816C6 Q47658809-3868341D-35F3-4E5B-9231-CB322BB53D05 Q50203849-B0AFA0C2-D379-433C-A514-9B17BC6E0AA1 Q51562958-C6F31B31-DA83-4DEF-A6B5-A34690E63FB0 Q53420685-043649C5-B5AB-41C5-B6D3-FAFD275A6DF3 Q55259181-0A7A1A77-3124-405E-808D-5BE1843B8C1E Q57111303-79C4DFEC-C8B7-4FAE-AD9D-D3A7DC858DEE Q58572903-F8A0A6F6-D0AC-49D2-B968-FACF063F91A4

P2860

Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures.

http://www.wikidata.org/entity/Q42917130

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures.

@en

Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures.

@nl

type

label

Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures.

@en

Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures.

@nl

prefLabel

Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures.

@en

Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures.

@nl

P1433

Q42917130-5C699BD7-9A59-400F-97EC-6564B26B9584

P1476

Q42917130-FD6428D3-0FBF-4A23-B088-BE0822B8ADEA

P2093

Q42917130-05447D69-8E6D-4303-B593-D37191A97F5E

Q42917130-09CA4BC3-C0DA-41F9-978A-66BF549F5D15

Q42917130-14DD909F-A26E-4B8A-ABF5-7927C2DC03E9

P2860

Q42917130-008E4390-DB8D-4DCC-90A3-768BE2FB49A6

Q42917130-019D9636-CA78-470B-830C-B66E11128542

Q42917130-03DE3DC5-6D2E-4AE0-BE81-2D3FABC27E50

Q42917130-09EE3560-47A3-401F-B3CE-5C23F9A0E624

Q42917130-0E400A3F-55B3-4544-9E21-15951F0BCF46

Q42917130-10644941-FCB4-42EA-AC78-740790BF228E

Q42917130-1B7484B0-EE69-4974-923D-FE7C17C313FC

Q42917130-25815B7C-185E-48FA-8A90-F731ADC81740

Q42917130-27D42F2C-4E33-48FC-B874-8F7C62CED036

Q42917130-2E1F6D51-6A2B-49C9-9A78-1994D044BFAB

P304

Q42917130-5EB3BA4A-DF28-403A-84B9-AA8DE98715F5

P31

Q42917130-352343B7-90E7-4B67-9AAA-285CD9C80307

P356

Q42917130-0A7FC116-FD99-4E4A-974C-FD12FC39CC96

P478

Q42917130-EA29659B-FEDE-4F75-9D2E-9B19F8EAE872

P50

Q42917130-207F16E3-390F-4347-AF31-3BBE9B7484A6

P577

Q42917130-77D8888B-86B1-435B-BF43-BBE736E0D38E

P5875

Q42917130-0E1A1DED-2371-4B00-8411-4A7A8F554FC8

P698

Q42917130-A0F35E3E-52C2-4E3C-8E64-2EA719209885

P921

Q42917130-FBE878C5-76D8-49FC-94A8-81552C551A40

P932

Q42917130-F5C3E3DC-483F-458D-9068-0FD0880A799B

P356

FGENE.2013.00116

P1433

Frontiers in Genetics

P1476

Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures.

@en

P2093

Dharanija Madhavan

http://www.w3.org/2001/XMLSchema#string

Katarina Cuk

http://www.w3.org/2001/XMLSchema#string

Rongxi Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients

Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers

Characterization of extracellular circulating microRNA

Circulating microRNAs as stable blood-based markers for cancer detection.

Cancer statistics, 2012

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

Circulating MiR-125b as a marker predicting chemoresistance in breast cancer

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.

Circulating microRNAs in breast cancer and healthy subjects

P304

116

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FGENE.2013.00116

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Barbara Burwinkel

P577

2013-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

242017946

http://www.w3.org/2001/XMLSchema#string

P698

23802013

http://www.w3.org/2001/XMLSchema#string

P921

P932

3689027

http://www.w3.org/2001/XMLSchema#string